TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2020 DA - 2020// TI - Cancer statistics, 2020 JO - CA Cancer J Clin VL - 70 UR - https://doi.org/10.3322/caac.21590 DO - 10.3322/caac.21590 ID - Siegel2020 ER - TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Xu, J. PY - 2010 DA - 2010// TI - Cancer statistics, 2010 JO - CA Cancer J Clin VL - 60 UR - https://doi.org/10.3322/caac.20073 DO - 10.3322/caac.20073 ID - Jemal2010 ER - TY - JOUR AU - Kelly, S. P. AU - Anderson, W. F. AU - Rosenberg, P. S. PY - 2018 DA - 2018// TI - Past, current, and future incidence rates and burden of metastatic prostate Cancer in the United States JO - Eur Urol Focus VL - 4 UR - https://doi.org/10.1016/j.euf.2017.10.014 DO - 10.1016/j.euf.2017.10.014 ID - Kelly2018 ER - TY - JOUR AU - Artibani, W. AU - Porcaro, A. B. AU - Marco, V. PY - 2018 DA - 2018// TI - Management of Biochemical Recurrence after primary curative treatment for prostate Cancer: a review JO - Urol Int VL - 100 UR - https://doi.org/10.1159/000481438 DO - 10.1159/000481438 ID - Artibani2018 ER - TY - JOUR AU - Cooperberg, M. R. AU - Pasta, D. J. AU - Elkin, E. P. PY - 2005 DA - 2005// TI - The University of California, san Francisco Cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy JO - J Urol VL - 173 UR - https://doi.org/10.1097/01.ju.0000158155.33890.e7 DO - 10.1097/01.ju.0000158155.33890.e7 ID - Cooperberg2005 ER - TY - JOUR AU - Cooperberg, M. R. AU - Hilton, J. F. AU - Carroll, P. R. PY - 2011 DA - 2011// TI - The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy JO - Cancer VL - 117 UR - https://doi.org/10.1002/cncr.26169 DO - 10.1002/cncr.26169 ID - Cooperberg2011 ER - TY - JOUR AU - Cooperberg, M. R. PY - 2017 DA - 2017// TI - Clinical risk-stratification for prostate cancer: where are we, and where do we need to go? JO - Can Urol Assoc J VL - 11 UR - https://doi.org/10.5489/cuaj.4520 DO - 10.5489/cuaj.4520 ID - Cooperberg2017 ER - TY - JOUR AU - Brajtbord, J. S. AU - Leapman, M. S. AU - Cooperberg, M. R. PY - 2017 DA - 2017// TI - The CAPRA score at 10 years: contemporary perspectives and analysis of supporting studies JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.08.065 DO - 10.1016/j.eururo.2016.08.065 ID - Brajtbord2017 ER - TY - JOUR AU - Tilki, D. AU - Mandel, P. AU - Schlomm, T. PY - 2015 DA - 2015// TI - External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohort JO - J Urol VL - 193 UR - https://doi.org/10.1016/j.juro.2014.12.020 DO - 10.1016/j.juro.2014.12.020 ID - Tilki2015 ER - TY - JOUR AU - Dalela, D. AU - Löppenberg, B. AU - Sood, A. PY - 2016 DA - 2016// TI - Contemporary role of the decipher® test in prostate Cancer management: current practice and future perspectives JO - Rev Urol VL - 18 ID - Dalela2016 ER - TY - JOUR AU - Loeb, S. AU - Ross, A. E. PY - 2017 DA - 2017// TI - Genomic testing for localized prostate cancer: where do we go from here? JO - Curr Opin Urol VL - 27 UR - https://doi.org/10.1097/MOU.0000000000000419 DO - 10.1097/MOU.0000000000000419 ID - Loeb2017 ER - TY - JOUR AU - Kern, A. AU - Partin, A. W. PY - 2013 DA - 2013// TI - Genetic tests for prostate cancer JO - Rev Urol VL - 15 ID - Kern2013 ER - TY - JOUR AU - Jeyapala, R. AU - Kamdar, S. AU - Olkhov-Mitsel, E. PY - 2020 DA - 2020// TI - An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients JO - Urol Oncol VL - 38 UR - https://doi.org/10.1016/j.urolonc.2019.08.017 DO - 10.1016/j.urolonc.2019.08.017 ID - Jeyapala2020 ER - TY - JOUR AU - Yang, H. AU - Liu, Y. AU - Bai, F. PY - 2013 DA - 2013// TI - Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.67 DO - 10.1038/onc.2012.67 ID - Yang2013 ER - TY - JOUR AU - Takayama, K. AU - Misawa, A. AU - Suzuki, T. PY - 2015 DA - 2015// TI - TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms9219 DO - 10.1038/ncomms9219 ID - Takayama2015 ER - TY - JOUR AU - Nickerson, M. L. AU - Das, S. AU - Im, K. M. PY - 2017 DA - 2017// TI - TET2 binds the androgen receptor and loss is associated with prostate cancer JO - Oncogene VL - 36 UR - https://doi.org/10.1038/onc.2016.376 DO - 10.1038/onc.2016.376 ID - Nickerson2017 ER - TY - JOUR AU - Kamdar, S. AU - Isserlin, R. AU - Kwast, T. PY - 2019 DA - 2019// TI - Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression JO - Clin Epigenetics VL - 11 UR - https://doi.org/10.1186/s13148-019-0651-z DO - 10.1186/s13148-019-0651-z ID - Kamdar2019 ER - TY - JOUR AU - Long, Q. AU - Xu, J. AU - Osunkoya, A. O. PY - 2014 DA - 2014// TI - Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-2699 DO - 10.1158/0008-5472.CAN-13-2699 ID - Long2014 ER - TY - JOUR PY - 2015 DA - 2015// TI - The molecular taxonomy of primary prostate Cancer JO - Cell VL - 163 UR - https://doi.org/10.1016/j.cell.2015.10.025 DO - 10.1016/j.cell.2015.10.025 ID - ref19 ER - TY - JOUR AU - Leyh-Bannurah, S. R. AU - Dell’Ogliod, P. AU - Zaffutod, E. PY - 2019 DA - 2019// TI - Assessment of oncological outcomes after radical prostatectomy according to preoperative and postoperative Cancer of the prostate risk assessment scores: results from a large, two-center experience JO - Eur Urol Focus VL - 5 UR - https://doi.org/10.1016/j.euf.2017.10.015 DO - 10.1016/j.euf.2017.10.015 ID - Leyh-Bannurah2019 ER - TY - JOUR AU - Lorent, M. AU - Maalmi, H. AU - Tessier, P. PY - 2019 DA - 2019// TI - Meta-analysis of predictive models to assess the clinical validity and utility for patient-centered medical decision making: application to the CAncer of the prostate risk assessment (CAPRA) JO - BMC Med Inform Decis Mak VL - 19 UR - https://doi.org/10.1186/s12911-018-0727-2 DO - 10.1186/s12911-018-0727-2 ID - Lorent2019 ER - TY - JOUR AU - Bach, C. AU - Pisipati, S. AU - Daneshwar, D. PY - 2014 DA - 2014// TI - The status of surgery in the management of high-risk prostate cancer JO - Nat Rev Urol VL - 11 UR - https://doi.org/10.1038/nrurol.2014.100 DO - 10.1038/nrurol.2014.100 ID - Bach2014 ER - TY - STD TI - Glass AG, Leo MC, Haddad Z, et al. Validation of a genomic classifier for predicting post-prostatectomy recurrence in a community based health care setting. J Urol. 195(6):1748–53. ID - ref23 ER - TY - JOUR AU - Léon, P. AU - Cancel-Tassin, G. AU - Drouin, S. PY - 2018 DA - 2018// TI - Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy JO - World J Urol VL - 36 UR - https://doi.org/10.1007/s00345-018-2290-y DO - 10.1007/s00345-018-2290-y ID - Léon2018 ER - TY - JOUR AU - Bishoff, J. T. AU - Freedland, S. J. AU - Gerber, L. PY - 2014 DA - 2014// TI - Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy JO - J Urol VL - 192 UR - https://doi.org/10.1016/j.juro.2014.02.003 DO - 10.1016/j.juro.2014.02.003 ID - Bishoff2014 ER - TY - JOUR AU - Kornberg, Z. AU - Cooperberg, M. R. AU - Spratt, D. E. PY - 2018 DA - 2018// TI - Genomic biomarkers in prostate cancer JO - Transl Androl Urol VL - 7 UR - https://doi.org/10.21037/tau.2018.06.02 DO - 10.21037/tau.2018.06.02 ID - Kornberg2018 ER - TY - JOUR AU - Nguyen, H. G. AU - Welty, C. AU - Lindquist, K. PY - 2018 DA - 2018// TI - Validation of GEMCaP as a DNA based biomarker to predict prostate Cancer recurrence after radical prostatectomy JO - J Urol VL - 199 UR - https://doi.org/10.1016/j.juro.2017.09.071 DO - 10.1016/j.juro.2017.09.071 ID - Nguyen2018 ER - TY - STD TI - Mahajan K, Malla P, Lawrence H, et al. ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR gene expression in castration-resistant prostate cancer. Cancer Cell. 31(6):790–803. ID - ref28 ER - TY - JOUR AU - Kim, H. AU - Lapointe, J. AU - Kaygusuz, G. PY - 2005 DA - 2005// TI - The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate Cancer JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-4562 DO - 10.1158/0008-5472.CAN-04-4562 ID - Kim2005 ER - TY - JOUR AU - Prudnikova, T. Y. AU - Soulitzis, N. AU - Kutsenko, O. S. PY - 2013 DA - 2013// TI - Heterogeneity of d-glucuronyl C5-epimerase expression and epigenetic regulation in prostate cancer JO - Cancer Med VL - 2 UR - https://doi.org/10.1002/cam4.108 DO - 10.1002/cam4.108 ID - Prudnikova2013 ER - TY - JOUR AU - Fladeby, C. AU - Gupta, S. N. AU - Barois, N. PY - 2008 DA - 2008// TI - Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells JO - Int J Cancer VL - 122 UR - https://doi.org/10.1002/ijc.23185 DO - 10.1002/ijc.23185 ID - Fladeby2008 ER - TY - JOUR AU - Shathasivam, P. AU - Kollara, A. AU - Spybey, T. PY - 2017 DA - 2017// TI - VEPH1 expression decreases vascularization in ovarian cancer xenografts and inhibits VEGFA and IL8 expression through inhibition of AKT activation JO - Br J Cancer VL - 116 UR - https://doi.org/10.1038/bjc.2017.51 DO - 10.1038/bjc.2017.51 ID - Shathasivam2017 ER - TY - STD TI - Feng H, Jia X-M, Gao N-N, et al. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway. Cell Cycle. 2019;18(21):2860–75. ID - ref33 ER - TY - JOUR AU - Abdel-Fatah, T. M. A. AU - Agarwal, D. AU - Liu, D. X. PY - 2016 DA - 2016// TI - SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)00174-1 DO - 10.1016/S1470-2045(16)00174-1 ID - Abdel-Fatah2016 ER - TY - JOUR AU - Zhang, H. AU - Li, S. AU - Yang, X. PY - 2016 DA - 2016// TI - miR-539 inhibits prostate cancer progression by directly targeting SPAG5 JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0337-8 DO - 10.1186/s13046-016-0337-8 ID - Zhang2016 ER - TY - STD TI - National Cancer Institute, National Human Genome Research Institute. The Cancer Genome Atlas Program: Human Subjects Protection and Data Access Policies. 2014. https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/policies/tcga-human-subjects-data-policies.pdf. Accessed 14 September 2020. UR - https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/history/policies/tcga-human-subjects-data-policies.pdf ID - ref36 ER -